CYTX
Cytori Therapeutics, Inc
Halal Rating :
Last Price
$1.16
Last updated:
Market Cap
-
7D Change
1.75%
1 Year Change
-47.98%
Company Overview
Exchange
Next Earnings Date
Cytori Therapeutics, Inc. was a biotechnology company that focused on developing cell therapies based on adipose-derived regenerative cells (ADRCs) for various medical conditions. The company appears to have undergone significant changes and there is limited current information available about its operations. Based on available data, the company seems to be experiencing financial difficulties with consistent operating losses.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $1.46m | $5.32m | - | $61000.0 | 0.00% | 1.15% |
| June 30, 2024 | $1.28m | $5.0m | - | $27000.0 | 0.00% | 0.54% |
| March 31, 2024 | $1.68m | $5.01m | - | $34000.0 | 0.00% | 0.68% |
Company Impact
Help us evaluate Cytori Therapeutics, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.